1 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; Therapeutic Apheresis Unit, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
2 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Children's University Hospital, AP-HP, Paris, France; Pediatric Immuno-Hematology and Rheumatology Unit, Necker Children's University Hospital, Paris, France.
3 Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
4 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Children's University Hospital, AP-HP, Paris, France; Pediatric Immuno-Hematology and Rheumatology Unit, Necker Children's University Hospital, Paris, France; Study Center of Immunodeficiency, Necker Children's University Hospital, Paris, France.
5 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France.
6 French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Children's University Hospital, AP-HP, Paris, France.
7 Pediatric Immuno-Hematology and Rheumatology Unit, Necker Children's University Hospital, Paris, France; Department of Microbiology, Necker Children's University Hospital, Paris, France; EA 7327, Paris Descartes University - Sorbonne Paris Cite, Paris, France.
8 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; Department of Clinical Hematology, Necker Children's University Hospital, Paris, France.
9 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; Pediatric Immuno-Hematology and Rheumatology Unit, Necker Children's University Hospital, Paris, France.
10 Department of Internal Medicine, Hotel-Dieu University Hospital, Nantes, France.
11 Department of Pediatric Hematology, Pellegrin University Hospital, Bordeaux, France.
12 Department of Pediatric Hematology and Oncology, Trousseau University Hospital, AP-HP, Paris, France.
13 Department of Hematology, Angers University Hospital, Angers, France.
14 Department of Internal Medicine, Caen University Hospital, Caen-Basse Normandie University, Caen, France.
15 Department of Hematology, Annecy-Genevois Hospital, Pringy, France.
16 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Children's University Hospital, AP-HP, Paris, France; Pediatric Immuno-Hematology and Rheumatology Unit, Necker Children's University Hospital, Paris, France; Collège de France, Paris, France.
17 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France; Biotherapy Department, Necker Children's University Hospital, Paris, France; Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, AP-HP, INSERM, Paris, France.
18 INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France. Electronic address: anne.durandy@inserm.fr.